Northern Trust Corp Pliant Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

A detailed history of Northern Trust Corp transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 477,165 shares of PLRX stock, worth $5.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
477,165
Previous 495,289 3.66%
Holding current value
$5.4 Million
Previous $7.38 Million 30.49%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$10.58 - $15.61 $191,751 - $282,915
-18,124 Reduced 3.66%
477,165 $5.13 Million
Q1 2024

May 14, 2024
SELL
$14.14 - $19.59 $141,923 - $196,624
-10,037 Reduced 1.99%
495,289 $7.38 Million
Q4 2023

Feb 13, 2024
BUY
$12.85 - $19.15 $4,754 - $7,085
370 Added 0.07%
505,326 $9.15 Million
Q3 2023

Nov 13, 2023
BUY
$14.58 - $20.15 $206,525 - $285,424
14,165 Added 2.89%
504,956 $8.76 Million
Q2 2023

Aug 11, 2023
BUY
$18.12 - $30.56 $7.01 Million - $11.8 Million
387,124 Added 373.43%
490,791 $8.89 Million
Q1 2023

May 15, 2023
BUY
$18.73 - $36.26 $417,585 - $808,416
22,295 Added 27.4%
103,667 $2.76 Million
Q4 2022

Feb 13, 2023
BUY
$17.0 - $25.43 $426,207 - $637,555
25,071 Added 44.53%
81,372 $1.57 Million
Q3 2022

Nov 14, 2022
BUY
$7.67 - $24.23 $142,201 - $449,224
18,540 Added 49.1%
56,301 $1.18 Million
Q2 2022

Aug 12, 2022
SELL
$4.11 - $8.75 $722,981 - $1.54 Million
-175,908 Reduced 82.33%
37,761 $302,000
Q1 2022

May 13, 2022
SELL
$7.01 - $14.1 $103,621 - $208,426
-14,782 Reduced 6.47%
213,669 $1.5 Million
Q4 2021

Feb 08, 2022
BUY
$12.27 - $18.26 $44,552 - $66,302
3,631 Added 1.62%
228,451 $3.08 Million
Q3 2021

Nov 15, 2021
BUY
$16.48 - $28.98 $143,343 - $252,068
8,698 Added 4.02%
224,820 $3.8 Million
Q2 2021

Aug 13, 2021
SELL
$28.05 - $37.69 $167,458 - $225,009
-5,970 Reduced 2.69%
216,122 $6.29 Million
Q1 2021

May 12, 2021
BUY
$24.52 - $40.23 $2.47 Million - $4.05 Million
100,556 Added 82.74%
222,092 $8.74 Million
Q4 2020

Feb 11, 2021
BUY
$19.89 - $32.99 $6,404 - $10,622
322 Added 0.27%
121,536 $2.76 Million
Q3 2020

Nov 16, 2020
BUY
$21.54 - $29.53 $2.61 Million - $3.58 Million
121,214 New
121,214 $2.75 Million

Others Institutions Holding PLRX

# of Institutions
158
Shares Held
63.8M
Call Options Held
481K
Put Options Held
105K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $551M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email